Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Obstetrics · Fetal Growth Restriction

How Do Early vs. Late FGR Affect Pregnancy Outcomes?

At a Glance

Early-onset fetal growth restriction before 32 weeks is more often linked to placental problems and pregnancy-related high blood pressure and may require premature delivery. Late-onset FGR at 32 weeks or later usually has better outcomes but is harder to detect and can still cause complications.

Your doctor diagnosing “early-onset” fetal growth restriction (FGR) means the growth restriction was detected before 32 weeks of pregnancy [1]. Because early-onset FGR is frequently tied to more extensive placental issues and a higher rate of preeclampsia, it is generally considered a higher-risk diagnosis than finding out in the third trimester [2][3]. Babies with early-onset FGR often need to be delivered prematurely because of reduced placental function, which introduces the risks of being born too early [4]. However, late-onset FGR (diagnosed at 32 weeks or later) presents its own distinct challenges, particularly because it can be much harder to detect and distinguish from a baby who is simply genetically small but perfectly healthy [5][6].

Here is a breakdown of the differences between early-onset and late-onset FGR, why they happen, and how they impact you and your baby.

Important Safety Warning: When to Call Your Doctor

Because FGR increases the risk of complications, you should not wait for your next scheduled ultrasound if you experience urgent symptoms. Contact your maternity unit immediately if you notice:

  • Markedly decreased or absent fetal movement
  • Severe or persistent headaches, or visual changes (like blurry vision or seeing spots)
  • Right-upper-abdominal or severe stomach pain
  • Vaginal bleeding or suspected fluid leakage
  • Very high blood pressure (if you are instructed to monitor at home)

Causes and Placental Health

While placental insufficiency—where the placenta doesn’t deliver enough oxygen and nutrients to the baby—is a major focus, FGR is a complex condition with many potential causes.

  • Early-Onset FGR: When FGR appears before 32 weeks, it is often associated with severe, widespread vascular problems within the placenta [2]. Because maternal blood flow to the baby is restricted early in pregnancy, early-onset FGR is heavily linked to preeclampsia (a maternal condition involving new high blood pressure and signs of organ stress, such as protein in the urine). In some early-FGR studies, preeclampsia occurs in 39% to 43% of cases [3][7]. However, not all early FGR is caused by the placenta; doctors may also evaluate for genetic conditions, fetal structural differences, or maternal infections [8][9][1].
  • Late-Onset FGR: Growth restriction that begins in the third trimester generally involves less severe placental damage [10]. The placenta may have functioned normally for most of the pregnancy but begins to age prematurely. Because the damage is less extensive, late-onset FGR is less strongly associated with preeclampsia, though it can still occur [3].

The Challenge of Detection

Paradoxically, while early-onset FGR is more severe, it is often easier to diagnose definitively. Late-onset FGR is more common but can be very tricky to catch.

  • Spotting Early-Onset FGR: Because the placental insufficiency in early FGR is usually severe, it frequently creates abnormalities on a Doppler ultrasound (a test that measures blood flow resistance in the umbilical cord) [5]. Worsening resistance (such as “absent or reversed end-diastolic flow”) signals substantial placental disease [1].
  • The Late-Onset “Disguise”: In late-onset FGR, the baby’s umbilical cord blood flow might appear completely normal [5]. This makes it difficult for doctors to tell the difference between a baby suffering from mild FGR and a baby who is perfectly healthy but just constitutionally small for their gestational age [11]. To help spot late-onset FGR, some care teams (depending on local guidelines) may check blood flow in the baby’s brain (the middle cerebral artery) to see if the baby is redirecting blood flow as an adaptation, though this test is not universally recommended for deciding when to deliver [5][12].

Differences in Care and Outcomes

The medical care you receive depends heavily on gestational age, Doppler findings, fetal testing, and your own health.

Early-Onset Care

Because early-onset FGR carries higher risks, monitoring is intensive. This may include serial ultrasounds to track growth, umbilical-artery Dopplers, and fetal heart rate monitoring (cardiotocography) [1][13]. The main goal for your doctor is to safely balance the risk of stillbirth against the hazards of severe prematurity [14].

If early delivery is anticipated within a specific timeframe, doctors often offer corticosteroids to help the baby’s lungs develop rapidly, and magnesium sulfate (if delivering very early) to help protect the baby’s brain [1][14]. According to guidelines from the Society for Maternal-Fetal Medicine (SMFM), delivery for severe early FGR might be considered between 30 and 34 weeks if blood flow is critically low (absent or reversed), but this is a general guideline and highly individualized to your specific test results [1]. Babies born this early face risks related to their prematurity, such as respiratory distress and immature immune systems in the neonatal intensive care unit (NICU) [4][15].

Late-Onset Care

Late-onset FGR generally has better outcomes because the baby has had more time to grow and avoid extreme prematurity [4]. However, late-onset FGR is not harmless. If it is missed, there remains a risk of stillbirth or distress during labor [16][17]. Babies with late-onset FGR may also experience issues like low blood sugar (hypoglycemia) or jaundice after birth, requiring extra pediatric attention [16].

For late-onset FGR, doctors typically aim for delivery between 37 and 39 weeks (depending on Doppler and growth results) to safely deliver the baby while avoiding unnecessary early induction complications [1].

Common questions in this guide

What is the difference between early-onset and late-onset fetal growth restriction?
Early-onset FGR is diagnosed before 32 weeks of pregnancy, while late-onset FGR is diagnosed at 32 weeks or later. Early-onset disease is more often linked to widespread placental problems and preeclampsia, while late-onset disease can be harder to distinguish from a healthy baby who is naturally small.
Does early-onset FGR have worse outcomes than late-onset FGR?
Early-onset FGR generally carries greater risk because reduced placental function may require delivery before the baby is ready, adding complications of prematurity. Late-onset FGR often has better outcomes because the baby has had more time to develop, but it can still lead to stillbirth, distress during labor, low blood sugar, or jaundice.
How do doctors tell late-onset FGR from a naturally small baby?
They consider estimated fetal weight, abdominal circumference, growth over time, blood-flow measurements on Doppler ultrasound, and other fetal testing. A baby who is small but healthy may have normal blood flow and reassuring tests, while FGR may show poor growth or signs that the baby is adapting to reduced placental function.
What does an abnormal umbilical artery Doppler mean in FGR?
It can indicate that the placenta is offering more resistance to blood flow, which may mean the baby is receiving less oxygen and nutrients. Absent or reversed blood flow at the end of the heartbeat is especially concerning and may lead to closer monitoring or earlier delivery.
When might delivery be recommended for a pregnancy affected by FGR?
Timing depends on gestational age, growth, umbilical-artery Doppler results, fetal testing, and the pregnant person's health. Severe early-onset FGR may require delivery well before term, while late-onset FGR is often delivered around 37 to 39 weeks when testing and growth support that plan.
What should I do if I notice warning signs with FGR?
Contact your maternity unit immediately for markedly decreased fetal movement, vaginal bleeding, suspected fluid leakage, severe headache, vision changes, upper-abdominal pain, or very high blood pressure. Do not wait for the next scheduled ultrasound when these symptoms occur.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are my baby's estimated fetal weight and abdominal-circumference percentiles, and how are they trending?
  2. 2.Based on the ultrasound, is this considered small-for-gestational-age or FGR, and what specific evidence supports that distinction?
  3. 3.What exact umbilical-artery Doppler pattern do I have, and how does it influence my monitoring schedule?
  4. 4.What specific symptoms or changes in test results would cause us to change the delivery plan?
  5. 5.If we need to deliver early, can we arrange a consultation with the neonatology (NICU) team beforehand?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).

    , Martins JG, Biggio JR, Abuhamad A

    American journal of obstetrics and gynecology 2020; (223(4)):B2-B17 doi:10.1016/j.ajog.2020.05.010.

    PMID: 32407785
  2. 2

    Pathologic placental lesions in early and late fetal growth restriction.

    Spinillo A, Gardella B, Adamo L, et al.

    Acta obstetricia et gynecologica Scandinavica 2019; (98(12)):1585-1594 doi:10.1111/aogs.13699.

    PMID: 31370094
  3. 3

    Preeclampsia and late fetal growth restriction.

    Marasciulo F, Orabona R, Fratelli N, et al.

    Minerva obstetrics and gynecology 2021; (73(4)):435-441 doi:10.23736/S2724-606X.21.04809-7.

    PMID: 33949823
  4. 4

    Early-onset fetal growth restriction: A systematic review on mortality and morbidity.

    Pels A, Beune IM, van Wassenaer-Leemhuis AG, et al.

    Acta obstetricia et gynecologica Scandinavica 2020; (99(2)):153-166 doi:10.1111/aogs.13702.

    PMID: 31376293
  5. 5

    Diagnosis and surveillance of late-onset fetal growth restriction.

    Figueras F, Caradeux J, Crispi F, et al.

    American journal of obstetrics and gynecology 2018; (218(2S)):S790-S802.e1 doi:10.1016/j.ajog.2017.12.003.

    PMID: 29422212
  6. 6

    A clinically oriented scoring system for placental pathology tested in late-onset fetal growth restriction and small-for-gestational-age pregnancies.

    Bonke-Falcao M, Markert UR, Lobmaier SM, Turowski G

    Placenta 2026; (181()):72-87 doi:10.1016/j.placenta.2026.04.018.

    PMID: 42102668
  7. 7

    Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe.

    Frusca T, Todros T, Lees C, et al.

    American journal of obstetrics and gynecology 2018; (218(2S)):S783-S789 doi:10.1016/j.ajog.2017.12.226.

    PMID: 29422211
  8. 8

    The genetics and clinical outcomes in 151 cases of fetal growth restriction: A Chinese single-center study.

    Peng C, Hu L, Bu X, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (298()):128-134 doi:10.1016/j.ejogrb.2024.05.004.

    PMID: 38756052
  9. 9

    Genetic syndromes associated with isolated fetal growth restriction.

    Meler E, Sisterna S, Borrell A

    Prenatal diagnosis 2020; (40(4)):432-446 doi:10.1002/pd.5635.

    PMID: 31891188
  10. 10

    Association Between Placental Pathology and Early-Onset Fetal Growth Restriction: A Systematic Review.

    Pinheiro B, Sarmento-Gonçalves I, Ramalho C

    Fetal and pediatric pathology 2025; (44(1)):40-52 doi:10.1080/15513815.2024.2437642.

    PMID: 39659194
  11. 11

    Diagnostic performance of 32 vs 36 weeks ultrasound in predicting late-onset fetal growth restriction and small-for-gestational-age neonates: a systematic review and meta-analysis.

    Mustafa HJ, Javinani A, Muralidharan V, Khalil A

    American journal of obstetrics & gynecology MFM 2024; (6(1)):101246 doi:10.1016/j.ajogmf.2023.101246.

    PMID: 38072237
  12. 12

    A critical review of placental function evaluation near term using Doppler ratios.

    Seravalli V, Hecher K, Baschat AA

    American journal of obstetrics and gynecology 2026; (234(4)):1007-1014 doi:10.1016/j.ajog.2025.11.032.

    PMID: 41285213
  13. 13

    Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials.

    Ganzevoort W, Thornton JG, Marlow N, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2020; (55(1)):68-74 doi:10.1002/uog.20354.

    PMID: 31125465
  14. 14

    Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.

    McCowan LM, Figueras F, Anderson NH

    American journal of obstetrics and gynecology 2018; (218(2S)):S855-S868 doi:10.1016/j.ajog.2017.12.004.

    PMID: 29422214
  15. 15

    Doppler abnormalities and perinatal outcomes in pregnant women with early-onset fetal growth restriction.

    Muniz CS, Dias BF, Motoyama PVP, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022; (35(25)):7276-7279 doi:10.1080/14767058.2021.1946786.

    PMID: 34233559
  16. 16

    Obstetric and pediatric growth charts for the detection of late-onset fetal growth restriction and neonatal adverse outcomes.

    Fernandez-Rodriguez B, de Alba C, Galindo A, et al.

    Journal of perinatal medicine 2021; (49(2)):216-224 doi:10.1515/jpm-2020-0210.

    PMID: 33027055
  17. 17

    Antenatal identification of early- and late-onset fetal growth restriction and the possible impact of the introduction of cerebroplacental ratio: Effect on perinatal and childhood outcome.

    Hertting E, Herling L, Lindqvist PG, Wiberg-Itzel E

    PloS one 2025; (20(6)):e0325906 doi:10.1371/journal.pone.0325906.

    PMID: 40531933

This page is for informational purposes only and does not constitute medical advice. Your obstetric or maternal-fetal medicine team should interpret your baby's tests and personalize monitoring and delivery planning.

Get notified when new evidence is published on Placental insufficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.